Furthermore, DPYSL2 single‐gene GSEA analysis of AML data from TCGA database revealed a strong activation of the PI3K/AKT/ mTOR pathway in patients in the DPYSL2 high expression group. The gene discussed is AKT1; the disease is acute myeloid leukemia.